ELV - NYSE
Elevance Health Inc.
$391.27
-2.8%Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
At a Glance
Live Snapshotelv
Other Non-Cash Items
Last Annual Value
363.00M
3-Year CAGR
11%
5-Year CAGR
87%
10-Year CAGR
16%
Elevance Health Inc. Competitors Analysis of Other Non-Cash Items
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Elevance Health Inc. NYSE:ELV | 363.00M | -32.4% | N/A | 13.1% | |
 Humana Inc. NYSE:HUM | 375.00M | -8.3% | N/A | 19.0% | |
 Becton, Dickinson and Company NYSE:BDX | 306.00M | 23.1% | 32.5% | 0.2% | |
 Cencora, Inc. NYSE:COR | 2.27B | 95.3% | N/A | 19.1% | |
 Zoetis Inc. NYSE:ZTS | 121.00M | 57.4% | 4.7% | 0.9% | |
 Cigna Corporation NYSE:CI | 11.00M | -80.9% | N/A | N/A | |
 IDEXX Laboratories, Inc. NASDAQ:IDXX | 69.73M | 109.8% | 49.8% | N/A | |
 CVS Health Corporation NYSE:CVS | 10.35B | 138.2% | 41.1% | 29.5% | |
 Regeneron Pharmaceuticals, Inc. NASDAQ:REGN | -810.60M | N/A | N/A | N/A | |
 GE HealthCare Technologies Inc. NASDAQ:GEHC | -517.00M | N/A | N/A | N/A |
Elevance Health Inc. Fair Value Envelope
Related Guides
Continue your ELV research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.